NextPlat Corp (NASDAQ:NXPL) Short Interest Down 12.7% in May

NextPlat Corp (NASDAQ:NXPL) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 449,800 shares, a decline of 12.7% from the April 30th total of 515,300 shares. Based on an average trading volume of 213,800 shares, the days-to-cover ratio is presently 2.1 days. Currently, 3.2% of the shares of the company are sold short.

Institutional Trading of NextPlat

A hedge fund recently raised its stake in NextPlat stock. Geode Capital Management LLC lifted its position in NextPlat Corp (NASDAQ:NXPL) by 54.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 165,459 shares of the company’s stock after purchasing an additional 58,402 shares during the period. Geode Capital Management LLC owned about 0.64% of NextPlat worth $179,000 as of its most recent SEC filing. 1.30% of the stock is owned by hedge funds and other institutional investors.

NextPlat Trading Up 1.9%

NASDAQ:NXPL opened at $0.65 on Thursday. The stock’s fifty day moving average price is $0.61 and its two-hundred day moving average price is $0.89. The company has a market cap of $16.94 million, a P/E ratio of -0.96 and a beta of 0.86. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.70 and a quick ratio of 3.04. NextPlat has a 1 year low of $0.43 and a 1 year high of $2.30.

NextPlat (NASDAQ:NXPL) last announced its earnings results on Thursday, May 15th. The company reported ($0.05) earnings per share (EPS) for the quarter. NextPlat had a negative net margin of 19.11% and a positive return on equity of 14.24%. The company had revenue of $14.53 million for the quarter.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.